Pang LN[Author] - Search Results

Year	Number of Results
2014	1
2016	2
2017	3
2018	1
2020	1
2021	1
2022	1
2023	0

1

Role of contrast-enhanced ultrasonography in MR-guided focused ultrasound ablation on uterus fibroids: lesion selection and assessment of ablative effects.

Luo W, Zhang PD, Yang X, Zheng JM, Liu Y, Tang X, Liu HJ, Ding L, Pang LN, Zhou XD, Liu LW, Zheng MW. Luo W, et al. Among authors: pang ln. Eur Radiol. 2022 Mar;32(3):2110-2119. doi: 10.1007/s00330-021-08294-x. Epub 2021 Nov 9. Eur Radiol. 2022. PMID: 34751794

2

Fluorine in the environment in an endemic fluorosis area in Southwest, China.

Yang JY, Wang M, Lu J, Yang K, Wang KP, Liu M, Luo HQ, Pang LN, Wang B. Yang JY, et al. Among authors: pang ln. Environ Res. 2020 May;184:109300. doi: 10.1016/j.envres.2020.109300. Epub 2020 Feb 27. Environ Res. 2020. PMID: 32192987

3

Stathmin is a marker of progression and poor prognosis in esophageal carcinoma.

Wang F, Xuan XY, Yang X, Cao L, Pang LN, Zhou R, Fan QX, Wang LX. Wang F, et al. Among authors: pang ln. Asian Pac J Cancer Prev. 2014;15(8):3613-8. doi: 10.7314/apjcp.2014.15.8.3613. Asian Pac J Cancer Prev. 2014. PMID: 24870766 Free article.

4

Metabolic profiling of tenacigenin B, tenacissoside H and tenacissoside I using UHPLC-ESI-Orbitrap MS/MS.

Zhao C, Han LY, Ren W, Zhao HY, Han SY, Zheng WX, Pang LN, Li XH, Li PP. Zhao C, et al. Among authors: pang ln. Biomed Chromatogr. 2016 Nov;30(11):1757-1765. doi: 10.1002/bmc.3750. Epub 2016 May 23. Biomed Chromatogr. 2016. PMID: 27106066

5

MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinoma.

Han SY, Han HB, Tian XY, Sun H, Xue D, Zhao C, Jiang ST, He XR, Zheng WX, Wang J, Pang LN, Li XH, Li PP. Han SY, et al. Among authors: pang ln. Oncotarget. 2016 Jul 5;7(27):42461-42473. doi: 10.18632/oncotarget.9886. Oncotarget. 2016. PMID: 27285759 Free PMC article.

6

Association of 4p14 and 6q27 variation with Graves disease: a case-control study and a meta-analysis of available evidence.

Li FM, Liu L, Pang LN, Shen M, Lu HW, Zhang XH, Chu X, Song ZJ. Li FM, et al. Among authors: pang ln. BMC Med Genet. 2017 May 18;18(1):56. doi: 10.1186/s12881-017-0406-7. BMC Med Genet. 2017. PMID: 28521825 Free PMC article.

7

Bu-Fei decoction and modified Bu-Fei decoction inhibit the growth of non-small cell lung cancer, possibly via inhibition of apurinic/apyrimidinic endonuclease 1.

Jiang ST, Han SY, Pang LN, Jiao YN, He XR, Li PP. Jiang ST, et al. Among authors: pang ln. Int J Mol Med. 2018 Apr;41(4):2128-2138. doi: 10.3892/ijmm.2018.3444. Epub 2018 Jan 30. Int J Mol Med. 2018. PMID: 29393411 Free PMC article.

8

Association Analysis of Single Nucleotide Polymorphisms in C1QTNF6, RAC2, and an Intergenic Region at 14q32.2 with Graves' Disease in Chinese Han Population.

Zhang XH, Shen M, Liu L, Li FM, Hu PC, Hua Q, Zhang J, Pang LN, Lu HW, Wang ZM, Chu X, Huang W. Zhang XH, et al. Among authors: pang ln. Genet Test Mol Biomarkers. 2017 Aug;21(8):479-484. doi: 10.1089/gtmb.2017.0009. Epub 2017 Jun 30. Genet Test Mol Biomarkers. 2017. PMID: 28665696

9

Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.

He XR, Han SY, Li XH, Zheng WX, Pang LN, Jiang ST, Li PP. He XR, et al. Among authors: pang ln. J Ethnopharmacol. 2017 May 23;204:45-57. doi: 10.1016/j.jep.2017.04.008. Epub 2017 Apr 12. J Ethnopharmacol. 2017. PMID: 28412214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results